bioRxiv Science⌕ Search

Biology subjects

Skrip, A. E.

Publications and source records attributed to Skrip, A. E..

2 recordsLinked to original sources

Mapping bacterial bile amidation across the bile salt hydrolase family

Evaluating enzyme activity and specificity in complex microbiomes is challenging. The recent discovery that bacterial bile salt hydrolases (BSHs) also function as transaminases in the human gut microbiome highlights what remains to be disentangled, even within one of the most extensively studied microbiomes. BSHs as transaminases can conjugate bile acids with bioavailable amines to produce bacterial bile amidates (BBAs). The implications of BBAs for human health are rapidly evolving, but our understanding of which BSHs produce which specific BBAs remains limited. Here, we connect BSH sequence and function by evaluating the transaminase activities of 115 BSHs and reveal distinct amine specificities using molecular networking. Additionally, we identify enzymatically generated BBAs distributed across life-stage, tissue-, and disease-specific human samples by mining public metabolomics repositories, highlighting the previously unrecognized catalytic diversity of BSHs and their potential relevance to human health.

biochemistry↗

A searchable metadata network graph for microbiome metabolomics

Establishing the biological context of microbial metabolites remains a major challenge. We present microbiomeMASST, a metadata-driven network graph that maps metabolites across 467 available datasets with 144,424 mass spectrometry files from humans, animals, and microbial culture systems. MicrobiomeMASST integrates monocultures, synthetic communities, and host-associated samples across multiple body sites and plants. MS/MS spectra can be queried to trace occurrence across hosts, experimental conditions, and interventions, enabling cross-study integration. We demonstrate this framework by contextualizing microbial-conjugated bile acids and interrogating microbiome-mediated drug metabolism. Screening gut bacteria revealed deprolylation of the angiotensin-converting enzyme (ACE) inhibitor prodrug enalapril. Using microbiomeMASST, we traced this metabolite across human cohorts, microbial isolates, environmental samples, and in Gorilla gorilla. Structural modeling and enzymatic assays showed that microbial deprolylation abolishes ACE inhibition, thereby inactivating its therapeutic effect. Together, microbiomeMASST links MS/MS spectra to biological context, converting isolated observations into an interpretable microbiome map for cross-study analysis.

biochemistry↗